Cargando...
Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens
Rationale: Azithromycin has been shown to improve lung function and reduce the number of pulmonary exacerbations in patients with cystic fibrosis. Concerns remain, however, regarding the potential emergence of treatment-related respiratory pathogens. Objectives: To determine whether chronic azithrom...
Gardado en:
| Publicado en: | Ann Am Thorac Soc |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Thoracic Society
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850787/ https://ncbi.nlm.nih.gov/pubmed/29474110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201801-012OC |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|